Issue 36, 2022, Issue in Progress

On-demand electrochemically controlled compound release from an ultrasonically powered implant

Abstract

On-demand drug delivery systems are promising for a wide range of therapeutic applications. When combined with wireless implants for controlled drug delivery, they can reduce overall dosage and side effects. Here, we demonstrate release of fluorescein from a novel on-demand release system for negatively charged compounds. The release system is based on a modified electroresponsive polypyrrole nanoparticulate film designed to minimize ion exchange with the stored compound – a major passive leakage mechanism. We further designed an ultrasonically powered mm-sized implant to electronically control the on-demand drug delivery system in vivo. Release kinetics are characterized both in vitro and in vivo in mice using fluorescein as a model drug, demonstrating the feasibility of wireless, controllable drug release using an ultrasonically powered implant.

Graphical abstract: On-demand electrochemically controlled compound release from an ultrasonically powered implant

Supplementary files

Article information

Article type
Paper
Submitted
01 Jun 2022
Accepted
09 Aug 2022
First published
17 Aug 2022
This article is Open Access
Creative Commons BY license

RSC Adv., 2022,12, 23337-23345

On-demand electrochemically controlled compound release from an ultrasonically powered implant

M. L. Wang, C. F. Chamberlayne, H. Xu, M. Mofidfar, S. Baltsavias, J. P. Annes, R. N. Zare and A. Arbabian, RSC Adv., 2022, 12, 23337 DOI: 10.1039/D2RA03422K

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements